Determination of Serum Lost Goodwill Target Proteome in Patients with Severe Traumatic Brain Injury

This study investigates the biokinetics of LGT proteome, a potential biomarker of severe TBI, in serum of severe TBI patients. The LGT proteome presents in the serum of severe TBI patients. The abundance diversity of LGT proteome is closely associated with pathologic condition of TBI patients. Serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Hongming, Hu, Changchen, Zhang, Gangli, Ren, Jinrui, Tan, Yihu, Sun, Wenxiao, Wang, Junwen, Li, Jun, Liu, Hongchao, Xie, Ruifan, Hao, Zhipeng, Guo, Dongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600481/
https://www.ncbi.nlm.nih.gov/pubmed/26491659
http://dx.doi.org/10.1155/2015/183821
Descripción
Sumario:This study investigates the biokinetics of LGT proteome, a potential biomarker of severe TBI, in serum of severe TBI patients. The LGT proteome presents in the serum of severe TBI patients. The abundance diversity of LGT proteome is closely associated with pathologic condition of TBI patients. Serum LGT proteome may be used as a promising marker for evaluating severity of severe TBI.

Ejemplares similares